Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to learn more about the safety and dosing of sildenafil in infants.


Clinical Trial Description

Pharmacokinetics and safety of sildenafil will be studied in preterm infants who are receiving sildenafil per standard of care or 1 dose prescribed for the study. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01670136
Study type Interventional
Source University of North Carolina, Chapel Hill
Contact
Status Completed
Phase Phase 1
Start date February 2013
Completion date July 2016

See also
  Status Clinical Trial Phase
Completed NCT04328636 - Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn Phase 1/Phase 2
Recruiting NCT02380040 - Plethismographic Perfusion Index in Neonates N/A
Withdrawn NCT01360671 - IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn Phase 2
Terminated NCT02261883 - Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn Phase 2
Completed NCT04841070 - NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn N/A
Recruiting NCT05741229 - The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns N/A
Recruiting NCT00710177 - PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Completed NCT02940327 - Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN
Terminated NCT01389856 - Persistent Pulmonary Hypertension of the Newborn Phase 3
Terminated NCT01069861 - Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) Phase 2
Active, not recruiting NCT02951130 - Milrinone in Congenital Diaphragmatic Hernia Phase 2
Enrolling by invitation NCT04938167 - Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension N/A
Not yet recruiting NCT04379180 - Population Pharmacokinetics and Dosage Individualization of Oral Pulmonary Vasodilators in PPHN